Emily K. Blue

608 total citations
19 papers, 497 citations indexed

About

Emily K. Blue is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Obstetrics and Gynecology. According to data from OpenAlex, Emily K. Blue has authored 19 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Pediatrics, Perinatology and Child Health and 7 papers in Obstetrics and Gynecology. Recurrent topics in Emily K. Blue's work include Pregnancy and preeclampsia studies (7 papers), Birth, Development, and Health (7 papers) and Gestational Diabetes Research and Management (7 papers). Emily K. Blue is often cited by papers focused on Pregnancy and preeclampsia studies (7 papers), Birth, Development, and Health (7 papers) and Gestational Diabetes Research and Management (7 papers). Emily K. Blue collaborates with scholars based in United States. Emily K. Blue's co-authors include Patricia J. Gallagher, Yijun Jin, Shelley A.H. Dixon, Zhili Shao, Ling Hou, Robert B. Wysolmerski, Laura S. Haneline, Kaela M. Varberg, B. Paul Herring and Zoe M. Goeckeler and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Diabetes.

In The Last Decade

Emily K. Blue

18 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily K. Blue United States 12 343 113 61 58 52 19 497
Xuesong Yang China 11 343 1.0× 97 0.9× 24 0.4× 43 0.7× 17 0.3× 19 481
Congshan Sun United States 12 334 1.0× 142 1.3× 68 1.1× 132 2.3× 64 1.2× 14 526
Julie S. Trausch‐Azar United States 17 614 1.8× 109 1.0× 40 0.7× 23 0.4× 104 2.0× 20 741
Laëtitia Chotard Canada 5 413 1.2× 76 0.7× 20 0.3× 147 2.5× 30 0.6× 6 548
Tiana A. Garrett United States 6 233 0.7× 144 1.3× 46 0.8× 12 0.2× 57 1.1× 7 456
Linh Nguyen Australia 8 397 1.2× 48 0.4× 51 0.8× 45 0.8× 56 1.1× 11 515
Bhola Shankar Pradhan India 12 199 0.6× 38 0.3× 48 0.8× 21 0.4× 28 0.5× 18 486
Henrik Jörnvall Sweden 8 473 1.4× 43 0.4× 21 0.3× 22 0.4× 28 0.5× 20 581
Carolyn V. Taylor United States 7 171 0.5× 41 0.4× 124 2.0× 60 1.0× 17 0.3× 7 360
W. H. Davin Townley-Tilson United States 8 559 1.6× 69 0.6× 22 0.4× 23 0.4× 43 0.8× 12 727

Countries citing papers authored by Emily K. Blue

Since Specialization
Citations

This map shows the geographic impact of Emily K. Blue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily K. Blue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily K. Blue more than expected).

Fields of papers citing papers by Emily K. Blue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily K. Blue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily K. Blue. The network helps show where Emily K. Blue may publish in the future.

Co-authorship network of co-authors of Emily K. Blue

This figure shows the co-authorship network connecting the top 25 collaborators of Emily K. Blue. A scholar is included among the top collaborators of Emily K. Blue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily K. Blue. Emily K. Blue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ferdinand, Keith C., Julia P. Dunn, Claudia Nicolay, et al.. (2023). Weight-dependent and weight-independent effects of dulaglutide on blood pressure in patients with type 2 diabetes. Cardiovascular Diabetology. 22(1). 49–49. 12 indexed citations
2.
Varberg, Kaela M., et al.. (2018). Transgelin Induces Dysfunction of Fetal Endothelial Colony-Forming Cells From Gestational Diabetic Pregnancies. PMC. 1 indexed citations
3.
Banno, Kimihiko, Yang Lin, Emily K. Blue, et al.. (2018). Mycophenolic acid induces senescence of vascular precursor cells. PLoS ONE. 13(3). e0193749–e0193749. 8 indexed citations
4.
Varberg, Kaela M., et al.. (2018). Transgelin induces dysfunction of fetal endothelial colony-forming cells from gestational diabetic pregnancies. American Journal of Physiology-Cell Physiology. 315(4). C502–C515. 19 indexed citations
5.
Varberg, Kaela M., Seth Winfree, Chenghao Chu, et al.. (2017). Kinetic analyses of vasculogenesis inform mechanistic studies. PMC.
6.
Varberg, Kaela M., Seth Winfree, Chenghao Chu, et al.. (2017). Kinetic analyses of vasculogenesis inform mechanistic studies. American Journal of Physiology-Cell Physiology. 312(4). C446–C458. 9 indexed citations
7.
Blue, Emily K., et al.. (2016). Mesenchyme Homeobox 2 Enhances Migration of Endothelial Colony Forming Cells Exposed to Intrauterine Diabetes Mellitus. Journal of Cellular Physiology. 232(7). 1885–1892. 12 indexed citations
8.
Blue, Emily K., et al.. (2015). Epigenetic Regulation of Placenta-Specific 8 Contributes to Altered Function of Endothelial Colony-Forming Cells Exposed to Intrauterine Gestational Diabetes Mellitus. PMC. 1 indexed citations
10.
Blue, Emily K., Kimberly Ballman, Frances Boyle, et al.. (2014). Fetal hyperglycemia and a high-fat diet contribute to aberrant glucose tolerance and hematopoiesis in adult rats. Pediatric Research. 77(2). 316–325. 8 indexed citations
11.
Blue, Emily K., Ethel Derr‐Yellin, Juan Acosta, et al.. (2013). Gestational diabetes induces alterations in the function of neonatal endothelial colony-forming cells. Pediatric Research. 75(2). 266–272. 30 indexed citations
12.
Gallagher, Patricia J. & Emily K. Blue. (2013). Post-translational regulation of the cellular levels of DAPK. APOPTOSIS. 19(2). 306–315. 9 indexed citations
13.
Habegger, Kirk M., Whitney Sealls, Lixuan Tackett, et al.. (2011). Fat-induced membrane cholesterol accrual provokes cortical filamentous actin destabilisation and glucose transport dysfunction in skeletal muscle. Diabetologia. 55(2). 457–467. 45 indexed citations
14.
Zhou, Jiliang, Emily K. Blue, Guoqing Hu, & B. Paul Herring. (2008). Thymine DNA Glycosylase Represses Myocardin-induced Smooth Muscle Cell Differentiation by Competing with Serum Response Factor for Myocardin Binding. Journal of Biological Chemistry. 283(51). 35383–35392. 13 indexed citations
15.
Jin, Yijun, Emily K. Blue, & Patricia J. Gallagher. (2006). Control of Death-associated Protein Kinase (DAPK) Activity by Phosphorylation and Proteasomal Degradation. Journal of Biological Chemistry. 281(51). 39033–39040. 49 indexed citations
16.
Blue, Emily K., Zoe M. Goeckeler, Yijun Jin, et al.. (2002). 220- and 130-kDa MLCKs have distinct tissue distributions and intracellular localization patterns. American Journal of Physiology-Cell Physiology. 282(3). C451–C460. 65 indexed citations
17.
Jin, Yijun, Emily K. Blue, Shelley A.H. Dixon, Zhili Shao, & Patricia J. Gallagher. (2002). A Death-associated Protein Kinase (DAPK)-interacting Protein, DIP-1, Is an E3 Ubiquitin Ligase That Promotes Tumor Necrosis Factor-induced Apoptosis and Regulates the Cellular Levels of DAPK. Journal of Biological Chemistry. 277(49). 46980–46986. 90 indexed citations
18.
Jin, Yijun, Emily K. Blue, Shelley A.H. Dixon, et al.. (2001). Identification of a New Form of Death-associated Protein Kinase That Promotes Cell Survival. Journal of Biological Chemistry. 276(43). 39667–39678. 54 indexed citations
19.
Gallagher, Patricia J., et al.. (2000). Alterations in expression of myosin and myosin light chain kinases in response to vascular injury. American Journal of Physiology-Cell Physiology. 279(4). C1078–C1087. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026